Moat Ross sold KNSA
April 9, 2026 · Form 4 insider transaction
Moat Ross sold 1,703 shares of Kiniksa Pharmaceuticals International, plc at $46.69 per share, a transaction worth $79.5K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,703
Price
$46.69
Total value
$79.5K
InsiderMoat Ross
RoleOfficer
SecurityClass A Ordinary Share
Transaction codeS: Open-market sale
Transaction dateApril 9, 2026
Filing dateApril 13, 2026
Shares owned after12,029
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on November 13, 2024.